The University of Chicago Header Logo

Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab.

Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab. Allergy. 2021 09; 76(9):2809-2826.

View in: PubMed